149 related articles for article (PubMed ID: 33865726)
1. Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.
Durieu I; Dalon F; Reynaud Q; Lemonnier L; Dehillotte C; Bérard M; Walther D; Viprey M; Van Ganse E; Belhassen M
J Cyst Fibros; 2022 Jan; 21(1):88-95. PubMed ID: 33865726
[TBL] [Abstract][Full Text] [Related]
2. Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.
Jackson AD; Jackson AL; Fletcher G; Doyle G; Harrington M; Zhou S; Cullinane F; Gallagher C; McKone E
Pharmacoeconomics; 2017 Oct; 35(10):1087-1101. PubMed ID: 28699086
[TBL] [Abstract][Full Text] [Related]
3. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.
Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D
Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685
[TBL] [Abstract][Full Text] [Related]
4. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
5. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007.
Briesacher BA; Quittner AL; Fouayzi H; Zhang J; Swensen A
Pediatr Pulmonol; 2011 Aug; 46(8):770-6. PubMed ID: 21465674
[TBL] [Abstract][Full Text] [Related]
6. Cost of cystic fibrosis: analysis of treatment costs in a specialized center in northern Italy.
Colombo C; Daccò V; Alicandro G; Loi S; Mazzi S; Lucioni C; Ravasio R
Adv Ther; 2013 Feb; 30(2):165-75. PubMed ID: 23397400
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.
Krauth C; Jalilvand N; Welte T; Busse R
Pharmacoeconomics; 2003; 21(14):1001-24. PubMed ID: 13129414
[TBL] [Abstract][Full Text] [Related]
8. Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010-2016.
Grosse SD; Do TQN; Vu M; Feng LB; Berry JG; Sawicki GS
Pediatr Pulmonol; 2018 Dec; 53(12):1611-1618. PubMed ID: 30381911
[TBL] [Abstract][Full Text] [Related]
9. Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study.
Mlčoch T; Klimeš J; Fila L; Vávrová V; Skalická V; Turnovec M; Krulišová V; Jirčíková J; Zemková D; Dědečková KV; Bílková A; Frühaufová V; Homola L; Friedmannová Z; Drnek R; Dřevínek P; Doležal T; Macek M
Eur J Health Econ; 2017 Jan; 18(1):73-82. PubMed ID: 26743971
[TBL] [Abstract][Full Text] [Related]
10. Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1.
Wildhagen MF; Verheij JB; Verzijl JG; Hilderink HB; Kooij L; Tijmstra T; ten Kate LP; Gerritsen J; Bakker W; Habbema JD
Thorax; 1996 Mar; 51(3):298-301. PubMed ID: 8779135
[TBL] [Abstract][Full Text] [Related]
11. The cost of medical care for patients with cystic fibrosis in a health maintenance organization.
Lieu TA; Ray GT; Farmer G; Shay GF
Pediatrics; 1999 Jun; 103(6):e72. PubMed ID: 10353969
[TBL] [Abstract][Full Text] [Related]
12. Understanding the costs of care for cystic fibrosis: an analysis by age and health state.
van Gool K; Norman R; Delatycki MB; Hall J; Massie J
Value Health; 2013; 16(2):345-55. PubMed ID: 23538187
[TBL] [Abstract][Full Text] [Related]
13. The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective.
Frey S; Stargardt T; Schneider U; Schreyögg J
Pharmacoeconomics; 2019 Aug; 37(8):1029-1039. PubMed ID: 30949989
[TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization and costs among children with cystic fibrosis in the United States.
Thorat T; McGarry LJ; Bonafede MM; Limone BL; Rubin JL; Jariwala-Parikh K; Konstan MW
Pediatr Pulmonol; 2021 Sep; 56(9):2833-2844. PubMed ID: 34138523
[TBL] [Abstract][Full Text] [Related]
15. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.
Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622
[TBL] [Abstract][Full Text] [Related]
16. Costs of treatment of adult patients with cystic fibrosis in Poland and internationally.
Kopciuch D; Zaprutko T; Paczkowska A; Nowakowska E
Public Health; 2017 Jul; 148():49-55. PubMed ID: 28404533
[TBL] [Abstract][Full Text] [Related]
17. Burden of cystic fibrosis in children <12 years of age prior to the introduction of CFTR modulator therapies.
Bresnick K; Arteaga-Solis E; Millar SJ; Laird G; LeCamus C
BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34857524
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary medication adherence and health-care use in cystic fibrosis.
Quittner AL; Zhang J; Marynchenko M; Chopra PA; Signorovitch J; Yushkina Y; Riekert KA
Chest; 2014 Jul; 146(1):142-151. PubMed ID: 24480974
[TBL] [Abstract][Full Text] [Related]
19. Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network.
Huot L; Durieu I; Bourdy S; Ganne C; Bellon G; Colin C; Touzet S;
J Cyst Fibros; 2008 Sep; 7(5):403-8. PubMed ID: 18358793
[TBL] [Abstract][Full Text] [Related]
20. Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis.
Levy JF; Rosenberg MA; Farrell PM
Pediatr Pulmonol; 2016 Dec; 51(12):1295-1303. PubMed ID: 27740724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
